Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Delia Radovich"'
Autor:
Howard S. Hochster, Hao Liu, Lyudmyla Derby Berim, Kristen Renee Spencer, Pat Gulhati, Manda DiRubbo, Seth D. Cohen, Patrick Lee, Stuart P. Leitner, Delia Radovich, Christian Misdary, Christian Perez, Sutirtha Datta, Andrea Gonzalez, Tracie Saunders, Patrick M Boland
Publikováno v:
Journal of Clinical Oncology. 41:144-144
144 Background: TAS-102 (trifluridine/tipiracil) is a novel oral antimetabolite for late line metastatic colorectal cancer (CRC) approved in 2018. Many patients are treated early in their course with oxaliplatin (OX), particularly adjuvant, and may b
Autor:
Eileen M. O'Reilly, Deborah Schrag, David H. Ilson, Leonard B. Saltz, Gary K. Schwartz, Stacey Kepler, William P. Tew, David P. Kelsen, Delia Radovich
Publikováno v:
Investigational New Drugs. 27:366-373
Objectives: To determine the maximum tolerated dose (MTD), toxicities, and suitable dose for weekly 1-h paclitaxel combined with weekly cisplatin and irinotecan to treat advanced gastrointestinal malignancies. Methods: Thirty patients with metastatic
Autor:
Miguel Conde, Stuart P. Leitner, Michael Scoppetuolo, Delia Radovich, Richard Alan Michaelson, Patricia C. Layton, Jennifer A. Wagmiller, Norma Alonzo Palma, I. Robert Grossman, Andrew Bennett Brown
Publikováno v:
Journal of Clinical Oncology. 33:e22054-e22054
e22054 Background: Comprehensive genomic profiling (CGP) of routinely fixed tissue from pts with advanced solid tumors can uncover tumor specific gene alterations. Foundation Medicine has developed a CLIA-certified, CAP-accredited test to simultaneou